Researching the Phenomenon of Poor Ovarian Responders and Management Strategies in IVF: A Narrative Review.

Q3 Medicine Acta medica academica Pub Date : 2022-08-01 DOI:10.5644/ama2006-124.379
Dionysios Galatis, Konstantina Kalopita, Ioannis Grypiotis, Ioannis Flessas, Nikolaos Kiriakopoulos, Georgia Micha
{"title":"Researching the Phenomenon of Poor Ovarian Responders and Management Strategies in IVF: A Narrative Review.","authors":"Dionysios Galatis,&nbsp;Konstantina Kalopita,&nbsp;Ioannis Grypiotis,&nbsp;Ioannis Flessas,&nbsp;Nikolaos Kiriakopoulos,&nbsp;Georgia Micha","doi":"10.5644/ama2006-124.379","DOIUrl":null,"url":null,"abstract":"<p><p>This narrative review aims to summarize all the latest studies published between 2015-2021 concerning the management protocols adopted for poor ovarian response (POR) cases. Patients defined as \"poor responders\" show minimal response to controlled ovarian hyperstimulation, although there is no standard definition for POR. Although infertility specialists are endeavoring to improve cycle outcomes in poor responders by adopting multiple management strategies, still the estimated risk of cycle cancellation is about 20%. All the studies performed during this study period were evaluated and their results were recorded. The latest published protocols to improve oocyte retrieval in poor responders include: anti-Mϋllerian hormone, clomiphene citrate, co-enzyme Q10, corifollitropin, dehydroepiandrosterone, double stimulation, Follicle Stimulation Hormone, Growth Hormone, Gonadotropin-releasing hormone agonists, letrozole, human chorionic gonadotropin, Luteinizing Hormone, progesterone and testosterone. CONCLUSION: Although many strategies have been suggested to manage POR, none has been proven superior to the others. Further large-scale randomized studies are needed to validate experimental techniques leading towards successful individualized treatment regimens.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"51 2","pages":"108-122"},"PeriodicalIF":0.0000,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3a/e3/AMA-51-108.PMC9982854.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta medica academica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5644/ama2006-124.379","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

This narrative review aims to summarize all the latest studies published between 2015-2021 concerning the management protocols adopted for poor ovarian response (POR) cases. Patients defined as "poor responders" show minimal response to controlled ovarian hyperstimulation, although there is no standard definition for POR. Although infertility specialists are endeavoring to improve cycle outcomes in poor responders by adopting multiple management strategies, still the estimated risk of cycle cancellation is about 20%. All the studies performed during this study period were evaluated and their results were recorded. The latest published protocols to improve oocyte retrieval in poor responders include: anti-Mϋllerian hormone, clomiphene citrate, co-enzyme Q10, corifollitropin, dehydroepiandrosterone, double stimulation, Follicle Stimulation Hormone, Growth Hormone, Gonadotropin-releasing hormone agonists, letrozole, human chorionic gonadotropin, Luteinizing Hormone, progesterone and testosterone. CONCLUSION: Although many strategies have been suggested to manage POR, none has been proven superior to the others. Further large-scale randomized studies are needed to validate experimental techniques leading towards successful individualized treatment regimens.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
体外受精中卵巢反应不良现象及处理策略的研究综述。
本综述旨在总结2015-2021年间发表的关于卵巢不良反应(POR)病例管理方案的所有最新研究。被定义为“不良反应”的患者对控制性卵巢过度刺激的反应最小,尽管对于不良反应没有标准的定义。尽管不孕症专家正在努力通过采用多种管理策略来改善不良反应者的周期结果,但估计周期取消的风险仍约为20%。本研究期间进行的所有研究均被评估并记录其结果。最新公布的改善不良应答者卵母细胞恢复的方案包括:anti-Mϋllerian激素、柠檬酸克罗米芬、辅酶Q10、corifolitropin、脱氢表雄酮、双重刺激、卵泡刺激激素、生长激素、促性腺激素释放激素激动剂、来曲唑、人绒毛膜促性腺激素、促黄体生成素、孕酮和睾酮。结论:虽然已经提出了许多策略来管理POR,但没有一种策略被证明优于其他策略。需要进一步的大规模随机研究来验证导致成功的个体化治疗方案的实验技术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Acta medica academica
Acta medica academica Medicine-Medicine (all)
CiteScore
1.90
自引率
0.00%
发文量
21
审稿时长
15 weeks
期刊最新文献
Multimodal Anesthesia-Analgesia for Patients with Huntington's Disease: A Case Series. An Ectopic External Jugular Vein Draining into the Axillary Vein: a Rare Anatomical Variation with Clinical Implications. A Round Ligament Mesothelial Cyst Imitating an Inguinal Hernia in a Woman of Reproductive Age. HPV-Related Cancers in Bosnia and Herzegovina: A Comprehensive Review. Institutional Experience of Lymphoproliferative Disorders with Initial Diagnosis Made via Fine Needle Aspiration at Otolaryngology Clinic.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1